MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 54 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,541 | -30.5% | 3,870,547 | -0.7% | 0.00% | -25.0% |
| Q2 2023 | $26,692 | -7.2% | 3,896,498 | +5.5% | 0.00% | 0.0% |
| Q1 2023 | $28,773 | +2.6% | 3,693,494 | +0.3% | 0.00% | -20.0% |
| Q4 2022 | $28,031 | -99.9% | 3,683,430 | -2.1% | 0.01% | 0.0% |
| Q3 2022 | $30,747,000 | -39.4% | 3,763,386 | -28.3% | 0.01% | -16.7% |
| Q2 2022 | $50,759,000 | -32.3% | 5,249,135 | -1.9% | 0.01% | -25.0% |
| Q1 2022 | $75,020,000 | -11.4% | 5,350,923 | +29.0% | 0.01% | 0.0% |
| Q4 2021 | $84,680,000 | +22.3% | 4,146,919 | +31.8% | 0.01% | +14.3% |
| Q3 2021 | $69,262,000 | +13.0% | 3,146,934 | +15.0% | 0.01% | +16.7% |
| Q2 2021 | $61,277,000 | – | 2,737,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |